Carole Ho

Companies

• Eli Lilly and CompanyEVP & Pres, Lilly Neuroscience Jan 6, 2026 to now¹
• Royalty Pharma plcBoard member Jul 25, 2025 to now²
• Beam TherapeuticsBoard member Feb 5, 2020 to now³
• Denali Therapeutics Inc.Chief Medical Officer Dec 7, 2017 to now⁴
• NGM Biopharmaceuticals (United States)Board member Jun 9, 2020 to Apr 8, 2024⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• DTDenali Therapeutics Inc. DNLI241,585 shares⁶$4.3M at $17.61Aug 14, 2025
• RPRoyalty Pharma plc RPRX13,103 shares⁷$783.7K at $59.81Jun 8, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 5, 2026Granted 4,545 shares of Royalty Pharma plc⁷
• Aug 13, 2025Sold 806 shares at $14.64 of Denali Therapeutics Inc.⁶
• Aug 12, 2025Sold 2,937 shares at $13.58 of Denali Therapeutics Inc.⁶
• Aug 5, 2025Exercised options 44,655 shares at $0.68 of Denali Therapeutics Inc.⁸
• Jul 31, 2025Granted 5,806 shares of Royalty Pharma plc⁹
• Jul 31, 2025Granted 2,752 shares of Royalty Pharma plc⁹
• Jan 7, 2025Sold 2,907 shares at $20.81 of Denali Therapeutics Inc.¹⁰
• Jan 6, 2025Sold 12,255 shares at $20.22 of Denali Therapeutics Inc.¹⁰
• Jan 3, 2025Granted 54,180 shares of Denali Therapeutics Inc.¹¹
• Nov 25, 2024Exercised options 17,845 shares at $0.68 of Denali Therapeutics Inc.¹²
• Aug 21, 2024Sold 5,907 shares at $24.96 of Denali Therapeutics Inc.¹³
• Aug 21, 2024Sold 14,098 shares at $24.41 of Denali Therapeutics Inc.¹³
• Aug 20, 2024Sold 2,453 shares at $23.79 of Denali Therapeutics Inc.¹³
• Aug 13, 2024Sold 2,337 shares at $22.89 of Denali Therapeutics Inc.¹⁴
• Feb 14, 2024Sold 1,405 shares at $17.79 of Denali Therapeutics Inc.¹⁵
• Feb 13, 2024Sold 2,784 shares at $17.29 of Denali Therapeutics Inc.¹⁵
• Jan 10, 2024Sold 4,668 shares at $19.02 of Denali Therapeutics Inc.¹⁶
• Jan 5, 2024Sold 9,972 shares at $19.43 of Denali Therapeutics Inc.¹⁷
• Jan 3, 2024Granted 53,720 shares of Denali Therapeutics Inc.¹⁸
• Aug 23, 2023Sold 2,522 shares at $23.22 of Denali Therapeutics Inc.¹⁹
• Aug 21, 2023Sold 2,478 shares at $22.60 of Denali Therapeutics Inc.²⁰
• Aug 14, 2023Sold 2,768 shares at $23.79 of Denali Therapeutics Inc.²¹
• Aug 10, 2023Sold 2,857 shares at $24.15 of Denali Therapeutics Inc.²²
• Feb 15, 2023Sold 1,476 shares at $29.40 of Denali Therapeutics Inc.²³
• Feb 13, 2023Sold 2,548 shares at $30.10 of Denali Therapeutics Inc.²⁴